An Act relative to pharmacists as healthcare providers

This bill allows pharmacists in Massachusetts to test for, screen, and initiate treatment for specific health conditions - including Influenza, Streptococcal infections, COVID-19, and HIV (including PrEP/PEP) - under a statewide protocol established by the Board of Pharmacy. It directly affects pharmacists (expanding their clinical role) and patients seeking accessible testing and initial treatment for these conditions. Key provisions require pharmacists to follow the protocol, delegate administrative tasks to technicians under supervision, and refer high-risk patients for hospital care when needed. The bill also mandates insurance companies to reimburse pharmacists for these services at standard rates for other healthcare providers, ensuring fair compensation.